Published on 6 Mar 2023 on Zacks via Yahoo Finance
Immuneering Corporation (IMRX) Reports Q4 Loss, Misses Revenue Estimates
Immuneering Corporation (IMRX) came out with a quarterly loss of $0.50 per share versus the Zacks Consensus Estimate of a loss of $0.58. This compares to loss of $0.42 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 13.79%. A quarter ago, it was expected that this company would post a loss of $0.48 per share when it actually produced a loss of $0.49, delivering a surprise of -2.08%.